Schrödinger, Inc. filings document an operating company with Software and Drug Discovery segments, including reported financial results, software revenue metrics, and disclosures about its computational platform for molecular discovery. Form 8-K reports furnish results of operations and material events, while other filings address clinical or regulatory disclosures and capital-structure matters.
Proxy and governance filings cover director elections, executive compensation, equity awards and shareholder voting matters. The record also includes disclosures about officer appointments, separation arrangements, compensatory matters, and voting rights for common stock and limited common stock, tying governance and ownership topics to the company's public-company structure.
Schrodinger, Inc. director and President & CEO Farid Ramy reported a mix of equity awards and a small share sale. He received a stock option for 112,500 shares, vesting 25% on March 2, 2027 with the remainder vesting monthly through March 2, 2030, subject to continued service. He also received several grants and vesting events of common stock and performance-based restricted stock units, and now holds common stock that includes 142,009 unvested RSUs. On the same date, he sold 5,560 shares of common stock at a weighted average price of $11.8977 per share under a pre-arranged Rule 10b5-1 plan to cover withholding taxes from PRSU vesting, which the footnotes state was not a discretionary trade.
Schrödinger, Inc.’s EVP & CFO Rachit Jain received new equity awards. On March 2, 2026, he was granted stock options covering 34,250 shares of common stock at an exercise price of $0.0000 per share, increasing his option holdings to 34,250 shares.
He also received a grant of 17,130 restricted stock units (RSUs), each representing one share of common stock, bringing his common stock holdings to 54,227 shares, which includes 52,660 unvested RSUs. The RSUs vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030. The options vest 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, in each case subject to his continued service with the company.
Tran Yvonne reported acquisition or exercise transactions in this Form 4 filing.
Schrodinger, Inc. executive Yvonne Tran, EVP, CLO & CPO, reported equity awards on March 2, 2026. She received a stock option for 34,250 shares with vesting of 25% on March 2, 2027 and the remainder in monthly installments through March 2, 2030, subject to continued service.
She was also granted 17,130 restricted stock units (RSUs) under the 2022 Equity Incentive Plan that vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030, subject to continued service. In addition, 13,788 performance-based RSUs from a March 4, 2024 grant had their performance metrics certified on March 2, 2026 and will vest upon the filing of the company’s Form 10-K for the year ended December 31, 2026, subject to continued service.
Schrodinger, Inc. executive Kenneth Patrick Lorton, EVP, CTO & COO, Software, reported equity awards consisting of stock options and restricted stock units. He received a stock option for 34,250 shares, granted on March 2, 2026, that vests 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, contingent on continued service.
He also acquired 17,130 RSUs under the company’s 2022 Equity Incentive Plan, vesting in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030, subject to continued service. In addition, 20,682 performance-based RSUs from prior 2024 grants were certified as earned on March 2, 2026 and will vest upon the filing of Schrodinger’s Form 10-K for the year ended December 31, 2026, if he remains with the company.
Schrodinger, Inc. chief accounting officer Jenny Herman reported equity awards consisting of stock options and restricted stock units. On March 2, 2026, she acquired options to purchase 8,220 shares of common stock and 9,590 RSUs, both at no cash cost as compensation.
The 9,590 RSUs were granted under the 2022 Equity Incentive Plan and will vest in four equal installments on March 9, 2027, 2028, 2029 and 2030, subject to continued service. The stock option grant is scheduled to vest 25% on March 2, 2027, with the remaining shares vesting in equal monthly installments through March 2, 2030. Following these awards, Herman directly holds 36,187 shares of common stock, including 26,875 unvested RSUs.
Schrodinger, Inc. executive Karen Akinsanya reported several equity awards and a small sale of shares. On March 2, 2026, she received a stock option for 48,500 shares and multiple grants or vesting events of common stock and restricted stock units under company equity plans, with future vesting stretching through 2030 and tied to performance certifications and continued service. The filing also shows the broker-assisted sale of 2,206 shares of common stock at a weighted average price of $11.992 per share under a pre-established Rule 10b5-1 instruction, executed solely to cover withholding taxes from performance-based RSU vesting and described as non-discretionary.
Schrodinger, Inc. officer Mannix Vartan Aklian reported equity awards consisting of stock options and restricted stock units under the company’s 2022 Equity Incentive Plan, as amended. The filing shows a grant of 34,250 stock options at an exercise price of $0.00 per share, with 25% of the underlying shares scheduled to vest on March 2, 2027 and the remaining shares vesting in equal monthly installments through March 2, 2030, subject to continued service.
In addition, Aklian received a grant of 17,130 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock. These RSUs were granted on March 2, 2026 and are scheduled to vest in equal installments on March 9, 2027, 2028, 2029 and 2030, also subject to continued service with the company. Following this grant, the reporting person holds 31,193 unvested RSUs in total.
Schrodinger, Inc. executive Robert Lorne Abel reported equity awards that increase his direct holdings. He received a stock option covering 34,250 shares, granted at an exercise price of $0.00 per share, scheduled to vest 25% on March 2, 2027 and monthly through March 2, 2030, subject to continued service.
He also acquired 17,130 restricted stock units (RSUs) that vest in four equal installments on March 9 of 2027, 2028, 2029 and 2030, and 20,682 performance-based RSUs tied to previously granted awards for which performance achievement was certified on March 2, 2026. These PRSUs are scheduled to vest upon the filing of the company’s Form 10-K for the year ended December 31, 2026, subject to continued service. Following these awards, his direct holdings include an aggregate of 52,949 unvested RSUs.